Cord Blood America Inc. Announces Earnings Results for the Third Quarter Ended September 30, 2015
November 16, 2015 at 01:17 pm
Share
Cord Blood America Inc. announced earnings results for the third quarter ended September 30, 2015. For the period, the company announced total revenue of $1.43 million compared to $1.20 million a year ago. The increase in revenue is due to growth in recurring storage fees and fees from other tissue related products.
Income from operations was $0.23 million compared to $1.51 million a year ago. EBITDA increased to $0.33 million from $0.15 million in 2014. The company's net income was $0.23 million compared to $1.51 million for the period ended September 30, 2014.
The decrease in net income for the three month period comparable period is primarily attributable to the change in the derivative liability and the discontinued operations which largely contributed to the gains for the period ending September 30, 2014.
CBA Florida, Inc., formerly Cord Blood America, Inc., through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. The Company's subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. The Company and its subsidiaries provides private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord's operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.
CBA FLORIDA, INC. 
